We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Blood Tests for Inflammation Can Be Discordant

By LabMedica International staff writers
Posted on 30 Oct 2012
The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels are widely used tests of inflammation that sometimes show opposite results. More...


However, CRP and ESR may not correlate substantially in some conditions, and the extent to which CRP and ESR results agree with each other in an unselected patient population is not clear in clinical practice, as the results of the two tests are sometimes different.

Scientists at the Texas Health Presbyterian Hospital (Dallas, TX, USA) performed 2,150 paired CRP/ESR measurements in 1,753 patients, between January and December of 2011. There were 1,731 patients who were not pregnant and were all adults aged 18 years or more. Initial CRP and ESR results for each patient were divided into quartiles.

The CRP assay performed is based on a reaction between CRP in a serum or plasma sample and polyclonal anti-CRP antibodies that have been adsorbed to latex particles the Multigent CRP Vario Reagent, (Sentinel; Milan, Italy). Agglutination is detected as an absorbance change at 572 nm on the Architect c8000 (Abbott Laboratories; Abbott Park, IL, USA). The ESR assay samples are read with an ESR-Auto Plus instrument in QuickMode (Streck; Omaha, NE, USA) and converted to Westergren units. The results can range from zero to greater than 120 mm/hour.

The ages of the 105 patients in the high CRP/low ESR–discordant group and the 107 in the high ESR/low CRP–discordant group were similar. The high CRP/low ESR–discordant group had more patients with infections than the high ESR/low CRP–discordant group particularly infections in the urinary tract, gastrointestinal tract, lungs and bloodstream. However, they had fewer bone and joint infections than the high ESR/low CRP–discordant group.

Connective tissue diseases, such as systemic lupus erythematosus, were less common in the high CRP/low ESR–discordant group than in the high ESR/low CRP–discordant group. Ischemic strokes or transient ischemic attacks almost invariably occurred in the high ESR/low CRP–discordant group, whereas myocardial infarction or venous thromboembolism was limited to the high CRP/low ESR–discordant group. The authors concluded that their findings will provide information to physicians who order these two tests together and receive discordant results, which occurs in approximately one in eight patients. The study was published on August 23, 2012, in the journal Translational Research.

Related Links:

Texas Health Presbyterian Hospital
Sentinel
Abbott Laboratories



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Quantitative lmmunoassay Test Menu
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.